Abstract
Stereoselective synthesis of (Z)-methyl 2-[(Z)-3-substituted 2-[2-(2,4-dinitrophenyl)hydrazono]-4-oxothiazolidine-5-ylidene]acetates and (Z)-methyl 2-[(Z)-3-substituted 2-[2-(tosylhydrazono)-4-oxothiazolidine-5-ylidene]acetates via the cyclization of N-substituted 2-arylhydrazino-carbothioamides with dialkyl acetylenedicarboxylates in absolute ethanol is reported. The structures were confirmed by spectroscopic data as well as single-crystal X-ray analyses. The mechanism of nucleophilic addition and the role of electronic factors were discussed. The anticancer activity of the newly synthesized compounds was evaluated against a panel of 60 cell lines derived from 9 different types of cancers including, leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate, and breast cancers and the results revealed that the cyclohexyl derivative has a significant broad anticancer activity, especially against different leukemia and colon cancer cell lines.
Graphic abstract
Similar content being viewed by others
References
Ahmed O, Salahuddin M, Vinutha K, Sharma P (2013) Int J Pharmaceut Res Schol 2:166
Koppireddi S, Komsani JR, Avula S, Pombala S, Vasamsetti S, Kotamraju S, Yadla R (2013) Eur J Med Chem 66:305
Ottanà R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, Chiricosta G, Di Paola R, Sautebin L, Cuzzocrea S, Vigorita MG (2005) Bioorg Med Chem 13:4243
Hu J, Wang Y, Wei X, Wu X, Chen G, Cao G, Shen X, Zhang X, Tang Q, Liang G, Li X (2013) Eur J Med Chem 64:292
Bhati SK, Kumar A (2008) Eur J Med Chem 43:2323
Hara A, Suzuki T, Hashizume H, Shishido N, Nakamura M, Ushikubi F, Abiko Y (1999) Eur J Pharmacol 385:81
Abhinit M, Ghodke M, Pratima NA (2009) Int J Pharm Pharmaceut Sci 1:47
Senthilraja M, Alagarsamy V, Solomon VR (2012) Lett Drug Des Discovery 9:731
Shiradkar MR, Ghodake M, Bothara KG, Bhandari SV, Nikalje A, Akula KC, Desai NC, Burange PJ (2007) Arkivoc xiv:58
Agrawal A, Lata S, Saxena KK, Srivastava VK, Kumar A (2006) Eur J Med Chem 41:1223
Ueno H, Oe T, Suehiro I, Nakamura F (1997) Preparation of 5-[2-naphthylmethyl(or methylene)]-thiazolidine-2,4-dionenes, -2-thioxy-thiazolidine-4-ones and -1H-tetrazoles for reducing blood sugar and blood lipid levels. U.S. patent 5,594,016, Jan. 14, 1997; (1997) Chem Abstr 126:157507
Ebeid MY, Fathallah OA, El-Zaher MI, Kamel MM, Abdou WAM, Anwer MM (1996) Bull Fac Pharm (Cairo Uni) 34:125
Rawal RK, Prabhakar YS, Katti SB, De Clercq E (2005) Bioorg Med Chem 13:6771
Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M (2004) Farmaco 59:33
Ravichandran V, Prashantha BRK, Sankar S, Agrawal RK (2009) Eur J Med Chem 44:1180
Aamer S, Naeem A, Ulrich F (2007) J Brazil Chem Soc 18:559
Darehkordi A, Saidi K, Islami MR (2007) Arkivoc i:180
Aly AA, Ishak EA, Brown AB (2014) J Sulfur Chem 35:382
Yavari I, Hosseini N, Moradi L (2008) Monatsh Chem 139:133
Kauss VY, Liepin’sh EE, Kalvin’sh IY, Lukevits E (1990) Chem Heterocycl Compd 26:103 [(1990) Khimiya Geterotsiklicheskikh Soedinenii 120]
Hassan AA, Abdel-Latif FF, Abdel Aziz M, Mostafa SM, Bräse S, Nieger M (2015) Chem Paper 69:973
Hassan AA, Mohamed NK, Makhlouf MM, Bräse S, Nieger M (2014) Synthesis 46:3097
Sarodnick G, Heydenreich M, Linker T, Kleinpeter E (2003) Tetrahedron 59:6311
Nandhrkumar R, Subramani K, Syde SS (2014) Int J Curr Res 6:5432
Schmeyers I, Kaupp G (2002) Tetrahedron 58:7241
Ahmad A, Saidi K, Khanazzadeh HM (2009) Mol Divers 13:353
Isikgor FH, Erol S, Dogan I (2014) Tetrahedron Asymmetry 25:449
Hassan AA, Aly AA, Bedair TM, Brown AB, El-Emary TI (2014) J Heterocycl Chem 51:44
Klika KD, Valtamo P, Janovec L, Suchár G, Kristian P, Imrich J, Kivelä H, Alföldi J, Pihlaja K (2004) Rapid Commun Mass 58:87
Sathishkumar M, Nagarajan S, Shanmugavelan P, Dinesh M, Ponnuswamy A (2013) Beilstein J Org Chem 9:689
Gürsoy A, Terzioğlu N (2005) Turk J Chem 29:247
Wagh YB, Kuwar AS, Patil DR, Tayade YA, Jangale AD, Terdale SS, Trivedi DR, Gallucci J, Dalal DS (2015) Int Eng Chem Res 54:9675
Laurent DRS, Gao Q, Wu D, Serrano-Wu MH (2004) Tetrahedron Lett 45:1907
Hassan AA, Mohamed NK, El-Shaieb KMA, Tawfeek HN, Bräse S, Nieger M (2019) Arabian J Chem 12:289
Joseph A, Shah CS, Kumar SS, Alex AT, Maliyakkal N, Moorkoth S, Mathew JE (2013) Acta Pharm 63:397
Liu K, Rao W, Parikh H, Li Q, Guo TL, Grant S, Kellogg GE, Zhang S (2012) Eur J Med Chem 47:125
Parashar B, Jain A, Bharadwaj S (2012) Med Chem Res 21:1692
Nalavde YM, Joshi V (2000) Indian J Chem Sect B Org Chem Incl Med Chem 39B:76
Karali N, Gürsoy A, Terzioğlu N, Özkrimh S, Özer H, Ekinci AC (1998) Arch Pharm-Pharm Med Chem 331:254
Luo Y, Ma L, Zheng H, Chen L, Li R, He C, Yang S, Ye X, Chen Z, Li Z, Gao Y, Han J, He G, Yang L, Wei Y (2010) J Med Chem 53:273
Sheldrick GM (2015) Acta Cryst A71:3
Sheldrick GM (2015) Acta Cryst C71:3
Parson S, Flack HD, Wagner T (2013) Acta Cryst B69:249
Acknowledgements
The authors thank the Science and Technology Development Fund, STDF, Egypt for its financial supporting of Grant No. 22934. Prof Alaa A. Hassan is indebted to the AvH-Foundation for the donation of a Shimadzu 408 IR instrument.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hassan, A.A., Aly, A.A., Ramadan, M. et al. Stereoselective synthesis of 2-(2,4-dinitrophenyl)hydrazono- and (2-tosylhydrazono)-4-oxo-thiazolidine derivatives and screening of their anticancer activity. Monatsh Chem 151, 1453–1466 (2020). https://doi.org/10.1007/s00706-020-02671-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-020-02671-w